Setini A, Beretta A, De Santis C, Meneveri R, Martayan A, Mazzilli M C, Appella E, Siccardi A G, Natali P G, Giacomini P
Center for Experimental Research, Regina Elena Institute, Rome, Italy.
Hum Immunol. 1996 Apr;46(2):69-81. doi: 10.1016/0198-8859(96)00011-0.
Only a few monoclonal antibodies are available with a restricted specificity to HLA-C products. In the present report, we demonstrate that antibody L31, previously shown to react with beta 2m-less (free) class I MHC heavy chains, binds to an epitope (residues 66-68 of the alpha 1 domain alpha helix) present on all the HLA-C alleles corresponding to the accepted (CW1 through CW8) serologic specificities, and on a few HLA-B heavy chains sharing with HLA-C an aromatic residue at position 67. Extensive IEF blot testing of HLA homozygous, EBV-transformed B-lymphoid cells indicates that HLA-C molecules are present at significantly lower levels than HLA-B polypeptides not only at cell surface, as previously demonstrated, but also in total cellular extracts. Testing of metabolically labeled HLA-CW1, -CW5, and -CW6 transfectants and HLA homozygous lymphoid cells, particularly HLA-CW1-expressing cells, demonstrates that the L31 epitope is present on a subpopulation of naturally occurring HLA-C molecules distinct from that identified by antibody W6/32 to beta 2m-associated heavy chains. Pulse-chase experiments demonstrate that this epitope is transiently made available to antibody binding at early biosynthetic stages, but becomes hidden upon assembly with beta 2m. Thus, free HLA-C and other Y/F67+ heavy chains are characterized by distinctive antibody binding features in a region (residues 66-68) included in a previously identified HLA-C restricted motif, which has been suggested to be the primary cause of distinctive features of the antigen-binding groove, low affinity for endogenous peptide antigens and beta 2m, and preferential uptake of exogenous peptides, possibly of viral origin. We also show that HLA-CW1 heavy chains, both free and beta 2m associated, acquire sialilation. Free HLA-CW1 heavy chains are expressed at the cell surface even when unsialilated, albeit at low levels.
目前仅有少数几种对HLA - C产物具有有限特异性的单克隆抗体。在本报告中,我们证明抗体L31(先前显示可与无β2m(游离)的I类MHC重链发生反应)可结合存在于所有与公认的(CW1至CW8)血清学特异性相对应的HLA - C等位基因以及一些在第67位与HLA - C共享芳香族残基的HLA - B重链上的一个表位(α1结构域α螺旋的第66 - 68位残基)。对HLA纯合的、EB病毒转化的B淋巴细胞进行广泛的IEF印迹检测表明,HLA - C分子不仅如先前所示在细胞表面的水平显著低于HLA - B多肽,而且在总细胞提取物中的水平也显著低于HLA - B多肽。对代谢标记的HLA - CW1、- CW5和 - CW6转染细胞以及HLA纯合淋巴细胞(特别是表达HLA - CW1的细胞)进行检测表明,L31表位存在于天然存在的HLA - C分子亚群上,该亚群不同于由针对与β2m相关的重链的抗体W6/32所识别的亚群。脉冲追踪实验表明,该表位在生物合成早期阶段会短暂地暴露于抗体结合,但在与β2m组装后会被隐藏。因此,游离的HLA - C和其他Y/F67 +重链在先前确定的HLA - C限制基序所包含的区域(第66 - 68位残基)具有独特的抗体结合特征,这被认为是抗原结合槽独特特征、对内源性肽抗原和β2m低亲和力以及优先摄取可能源自病毒的外源性肽的主要原因。我们还表明,游离的和与β2m相关的HLA - CW1重链都会发生唾液酸化。即使未进行唾液酸化,游离的HLA - CW1重链也会在细胞表面表达,尽管表达水平较低。